Cross-Border Platform Pursuing Advanced Modalities

GLOBAL INNOVATION
FORMATIVE R&D PARTNERSHIPS

We are on a mission to bring innovative medicines to patients in Asia and around the world.

Our mission

Founded in 2020, Overland Pharmaceuticals is establishing a leading cross-border platform company focused on advanced modalities through strategic partnering and in-house R&D. Overland is seeded by Hillhouse Capital with access to global innovation and China biopharma ecosystem.

Overland is building an initial oncology portfolio of first-in-class ADC and allogeneic cell therapy programs for greater China and Asia through partnering with established biotechs.

Through formative R&D partnerships and in-house technology platforms, Overland will move forward the development and commercialization of the most promising advances in medicine.

We collaborate with global partners to jointly move forward cutting-edge platform programs.

Our focus on clinical unmet need and innovation

We aim to build out a pipeline based on innovative, differentiated programs that are addressing meaningful clinical unmet needs for patients and are built on cutting-edge or advanced modality platforms.

Welcome to Overland.

We always believe great team and talents are the driving force behind Overland’s success.

We strive to find talents who share our vision, are dedicated to their work, and have great team spirits. We aim to provide competitive compensation package with comprehensive professional development resources to help each Overland’s talent’s future career growth.

Reach out to us for inquiries.

Our office locations

Shanghai

Beijing

Boston

Our email

General: info@overlandpharma.com

Business development and partnering: bd@overlandpharma.com